Close Menu

Money, Money

When Congress included NIH in the Recovery and Reinvestment Act and offered money for research, scientists were happy, but also complained that two years of funding wasn't enough time to do significant research, DrugMonkey says. "I thought this was stupid. More money into the research enterprise is a good thing, in my view. It displayed a shocking lack of can-do attitude and imagination on the part of scientists to react the way they did," he adds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.